Neoplastic cells are easily recognized using a multicolor approach for their characteristic loss of CD45 and for the frequent aberrant expression of CD21, a B cell antigen, in the context of a CD3+CD5+MHC II+ lymphoma (11, 12) (Figure 2). The gene discussed is CR2; the disease is lymphoma.